Content area
Full Text
The Carlyle Group on July 15 agreed to acquire nutritional supplements manufacturer/marketer NBTY for $3.8 billion, marking one of the first private equity mega-deals in the direct-to-consumer market since the recession began.
But some NBTY investors are not happy about the pending transaction and have prompted an investigation over possible fiduciary duty breaches and other violations by the NBTY board.
Lee Helman, managing...